Table 2. Correlation of distinct epitopes of BARD1 and BRCA1 expression with survival in 75 colorectal cancer patients.

			1-year survival		2-year survival		3-year survival
Expression pattern	No. of patients	Median survival	%	P -value	%	P -value	%	P -value
N neg vs pos	55 vs 20	11 vs 26	47.3 vs 85.0	0.0035	21.8 vs 50.0	0.0178	12.7 vs 40.0	0.009
P neg vs pos	14 vs 61	14 vs 15	57.1 vs 57.4	0.9873	28.6 vs 29.5	0.9446	21.4 vs 19.7	0.8822
W neg vs pos	4 vs 71
C neg vs pos	42 vs 33	9 vs 17	45.2 vs 72.7	0.0169	21.4 vs 39.4	0.0898	11.9 vs 30.3	0.048
BRCA1 neg vs pos	60 vs 15	16 vs 12	60.0 vs 46.7	0.3504	31.7 vs 20.0	0.3747	23.3 vs 6.7	0.1489

Note: ‘neg’, negative staining; ‘pos’, positive staining.

Antibody abbreviations: N - N19, P - PVC, C - C20, W - WFS. For WFS, negative staining cases were not enough for further analysis.